Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.57 |
| ▸ | VDR known ✓ | P11473 | 2/20 | 0.56 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.66 |
| ▸ | GPBAR1 | Q8TDU6 | 9/20 | 0.63 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.57 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.57 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.57 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.57 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.57 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.57 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.57 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.57 |
| ▸ | ABCC4 | O15439 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8333417 | 1.00 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL58082 | 0.99 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL18045259 | 0.99 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL4777980 | 0.99 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL55596 | 0.92 | EPHA2 (0.68) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL3789015 | 0.92 | EPHA2 (0.65) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Sulfuric Acid SCHEMBL2285700 | 0.92 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL905493 | 0.90 | EPHA2 (0.65) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL6027325 | 0.89 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Sulfuric Acid SCHEMBL5587293 | 0.89 | EPHA2 (0.68) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569595-B2 | Bioprosthetic tissue preparation | EDWARDS LIFESCIENCES CORPORATION (US) | 2026-03-10 | — | — | US | claimed |
| US-12492973-B2 | Methods for large tissue labeling, clearing and imaging | DEEP PICTION GMBH (DE) | 2025-12-09 | — | — | US | claimed |
| EP-4019646-B1 | METHODS AND KITS FOR DETECTING SPERM DNA FRAGMENTATION | BONRAYBIO CO LTD (TW) | 2025-06-11 | — | — | EP | claimed |
| EP-3810790-B1 | METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE | BIOMERIEUX SA (FR) | 2025-04-02 | — | — | EP | claimed |
| US-20250099650-A1 | Vascular Extracellular Matrix Hydrogel | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2025-03-27 | — | — | US | claimed |
| US-12153039-B2 | Methods and kits for detecting sperm dna fragmentation | BONRAYBIO CO., LTD. (TW) | 2024-11-26 | — | — | US | claimed |
| WO-2024213654-A1 | GENTLE METHOD FOR PRODUCING TRANSPARENT BIOLOGICAL PREPARATIONS FOR EXAMINATION BY LIGHT MICROSCOPY | GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS (UNIVERSITÄTSMEDIZIN) (DE) | 2024-10-17 | — | — | WO | claimed |
| EP-4446723-A1 | GENTLE METHOD FOR PRODUCING TRANSPARENT BIOLOGICAL PREPARATIONS FOR A LIGHT MICROSCOPIC EXAMINATION | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (DE) | 2024-10-16 | — | — | EP | claimed |
| EP-4428294-A2 | A METHOD FOR PREPARATION OF VIRUCIDAL POLYMER TEXTILE MATERIALS AND VIRUCIDAL FACE MASKS MADE FROM SAID MATERIALS | Jozef Stefan Institute (SI) | 2024-09-11 | — | — | EP | claimed |
| US-20240000169-A1 | A METHOD FOR PREPARATION OF VIRUCIDAL POLYMER TEXTILE MATERIALS AND VIRUCIDAL FACE MASKS MADE FROM SAID MATERIALS | Jo{hacek over (z)}ef Stefan Institute (SI) | 2024-01-04 | — | — | US | claimed |
| US-20200209118-A1 | METHODS FOR LARGE TISSUE LABELING, CLEARING AND IMAGING | DEEP PICTION GMBH (DE) | 2020-07-02 | — | — | US | claimed |
| EP-3635363-A1 | METHODS FOR LARGE TISSUE LABELING, CLEARING AND IMAGING | Ertürk, Ali (DE) | 2020-04-15 | — | — | EP | claimed |
| WO-2020002806-A1 | METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE | bioMérieux (FR) | 2020-01-02 | — | — | WO | claimed |
| WO-2018224289-A1 | METHODS FOR LARGE TISSUE LABELING, CLEARING AND IMAGING | ERTUERK ALI (DE) | 2018-12-13 | — | — | WO | claimed |
| EP-1949100-B1 | METHOD OF TACROLIMUS EXTRACTION AND QUANTIFICATION USING AQUEOUS DETERGENTS | ABBOTT LAB (US) | 2011-08-03 | — | — | EP | claimed |
| US-7718380-B2 | Method of tacrolimus extraction and quantification using aqueous detergents | ABBOTT LABORATORIES (US) | 2010-05-18 | — | — | US | claimed |
| US-20090275062-A1 | METHOD OF TACROLIMUS EXTRACTION AND QUANTIFICATION USING AQUEOUS DETERGENTS | ABBOTT LABORATORIES (US) | 2009-11-05 | — | — | US | claimed |
| EP-1949100-A1 | METHOD OF TACROLIMUS EXTRACTION AND QUANTIFICATION USING AQUEOUS DETERGENTS | ABBOTT LABORATORIES (US) | 2008-07-30 | — | — | EP | claimed |
| US-20070087396-A1 | Method of tacrolimus extraction and quantification using aqueous detergents | ABBOTT LABORATORIES | 2007-04-19 | — | — | US | claimed |
| WO-2007044978-A1 | METHOD OF TACROLIMUS EXTRACTION AND QUANTIFICATION USING AQUEOUS DETERGENTS | ABBOTT LABORATORIES (US) | 2007-04-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569595-B2 | Bioprosthetic tissue preparation | BCHE, LNPEP, DPEP1 | MEN1 4652/4885VDR 2271/4885EPHA2 811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.